Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniel J. Oh, Judy L. Chen, Thasarat S. Vajaranant & Mark S. Dikopf. (2019) Brimonidine tartrate for the treatment of glaucoma. Expert Opinion on Pharmacotherapy 20:1, pages 115-122.
Read now
Read now
Emilio Rintaro Suzuki$suffix/text()$suffix/text() & Cibele Lima Belico Suzuki. (2010) Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations. Clinical Ophthalmology 4, pages 1165-1171.
Read now
Read now
Articles from other publishers (3)
Sophie Lemmens, Luca Rossetti, Francesco Oddone, Gordana Sunaric-Mégevand, Anton Hommer, Evelien Vandewalle, Maria Francesca Cordeiro, Andrew McNaught, Giovanni Montesano & Ingeborg Stalmans. (2021) Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II. European Journal of Ophthalmology 32:2, pages 968-975.
Crossref
Crossref
Hiroyoshi Kasai, Yumiko Aoyama, Takashi Kurasawa, Tomoyo Imamura, Kazuhiro Tsuruma, Hideaki Hara, Haruhisa Hirata & Tetsuya Yamamoto. (2013) Comparison of Efficacy and Safety Evaluation of Latanoprost Formulations with and without Benzalkonium Chloride. Pharmacology & Pharmacy 04:04, pages 377-384.
Crossref
Crossref
Charles S. Tressler, Richard Beatty & Michael A. Lemp. (2011) Preservative Use in Topical Glaucoma Medications. The Ocular Surface 9:3, pages 140-158.
Crossref
Crossref